Stifel Nicolaus Lowers Trulieve Cannabis (OTCMKTS:TCNNF) Price Target to C$20.00

Trulieve Cannabis (OTCMKTS:TCNNF – Get Rating) had its target price reduced by research analysts at Stifel Nicolaus from C$25.00 to C$20.00 in a research report issued on Thursday, The Fly reports.

TCNNF has been the topic of several other reports. Alliance Global Partners cut their target price on shares of Trulieve Cannabis from C$24.00 to C$16.00 in a research report on Thursday. Craig Hallum dropped their price target on shares of Trulieve Cannabis from $20.00 to $10.00 in a research report on Thursday, March 9th. Needham & Company LLC dropped their price target on shares of Trulieve Cannabis from $14.25 to $12.00 and set a “buy” rating on the stock in a research report on Thursday, March 9th. Finally, Cantor Fitzgerald dropped their target price on shares of Trulieve Cannabis from $41.00 to $37.00 and set an “overweight” rating on the stock in a research report on Monday, March 6th.

Trulieve Cannabis Stock Down 4.1 %

Shares of Trulieve Cannabis stock opened at $4.48 on Thursday. The firm’s 50 day moving average is $5.55 and its 200 day moving average is $7.70. Trulieve Cannabis has a 1 year low of $4.35 and a 1 year high of $16.11.

About Trulieve Cannabis

(Get Rating)

Trulieve Cannabis Corp. engages in the provision of medical cannabis products and services. It cultivates and produces its products in-house and distributes to its branded stores, as well as directly to patients via home delivery. The company was founded by Kim Rivers on September 17, 1940 and is headquartered in Quincy, FL.